Advanced glycation end products promote human aortic smooth muscle cell calcification in vitro via activating NF-κB and down-regulating IGF1R expression

Involvement of Toxic AGEs (TAGE) in the Pathogenesis of Diabetic Vascular Complications and Alzheimer's Disease

(2017) Masayoshi Takeuchi et al.   JOURNAL OF ALZHEIMERS DISEASE

Advanced Glycation End-products Enhance Calcification in Vascular Smooth Muscle Cells

(2013) X Ren et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Advanced glycation end-product Nɛ-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes

(2012) Zhongqun Wang et al.   ATHEROSCLEROSIS

Activation of nuclear factor-kappa B accelerates vascular calcification by inhibiting ankylosis protein homolog expression

(2012) Gexin Zhao et al.   KIDNEY INTERNATIONAL

Calcium and osteoprotegerin regulate IGF1R expression to inhibit vascular calcification

(2011) B. A. Di Bartolo et al.   CARDIOVASCULAR RESEARCH

Involvement of RAGE, MAPK and NF-κB pathways in AGEs-induced MMP-9 activation in HaCaT keratinocytes

(2011) Ping Zhu et al.   EXPERIMENTAL DERMATOLOGY

Vascular calcification in chronic kidney disease: Figure 1

(2010) Adrian Covic et al.   CLINICAL SCIENCE

Smooth Muscle Cell Pathophysiology and Advanced Glycation End Products (AGEs)

(2010) Sho-ichi Yamagishi et al.   CURRENT DRUG TARGETS

Mechanistic study of endogenous skin lesions in diabetic rats

(2010) Xiang-fang Chen et al.   EXPERIMENTAL DERMATOLOGY

Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes

(2010) Sho-ichi Yamagishi   EXPERIMENTAL GERONTOLOGY

Advanced Glycation End Products Induce Calcification of Vascular Smooth Muscle Cells through RAGE/p38 MAPK

(2009) Takahisa Tanikawa et al.   JOURNAL OF VASCULAR RESEARCH

Mineral Surface in Calcified Plaque Is Like That of Bone

(2008) Melinda J. Duer et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Receptor for Advanced Glycation End Products (RAGE): A Novel Therapeutic Target for Diabetic Vascular Complication

(2008) Sho-ichi Yamagishi et al.   CURRENT PHARMACEUTICAL DESIGN

Expression, regulation and function of trail in atherosclerosis

(2007) Mary M. Kavurma et al.   BIOCHEMICAL PHARMACOLOGY